Press Releases
Public Relations: Andrew Noble
June 09, 2026
New
Accelerated Cure Project for MS Launches the ACP Data Challenge Pilot, a New Initiative to Explore One of the World's Most Comprehensive MS Research Ecosystems
A new model for open MS discovery invites the brightest minds in the field to interrogate ACP’s longitudinal and multi-omic MS data spanning decades in a single secure environment.
Read More
May 19, 2026
DNAnexus Scales AI-Driven Capabilities
17-Year Multiomics Pioneer Powers Next Era of Precision Health
Read More
May 07, 2026
DNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation Award
Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology
Read More
May 07, 2026
Longitude Prize on ALS Announces Stage 1 Discovery Award Winners
Meet the Discovery Awardees of the Longitude Prize on ALS, awarded £100,000 each, as well as access to the Prize datasets and a technical support package to drive their computational work. These 20 pioneering, global and multidisciplinary teams are using cutting-edge AI to unlock the complexity of ALS.
Read More
November 10, 2025
EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform
EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.
Read More
News
May 29, 2026
New
Immunai, AstraZeneca Expand Partnership, Rancho Biosciences Releases Multi-omics Datasets, Dotmatics AI Co-Scientist
By bridging the gap between raw multimodal data and clinical discovery, DNAnexus enables health leaders to operationalize AI across critical workflows with full regulatory readiness.
Read More
May 26, 2026
Programming biology: next-gen AI firms raise billions to design better medicines
Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
May 19, 2026
DNAnexus AI Products
DNAnexus has launched a number of software products and enhancements that are enabled by artificial intelligence.
Read More
May 01, 2026
How are companies distinguishing between “moonshot” automation and validated digital tools that can be deployed today?
Todd Oakland, Ph.D., Senior Vice President, General Manager, Biopharma RX/DX, DNAnexus, joins a roundtable of experts to discuss the pace of technological innovation and how to tell when a tool is production-ready.
Read More
March 31, 2026
AI-led selloff in contract research firms may be misjudging disruption risk
Shares of contract research organizations have tumbled on fears that advances in artificial intelligence could allow drugmakers to take clinical trial work in-house, but industry experts say the selloff overestimates how far the technology can replace the sector's core capabilities.
Read More
"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital